An Important Study You Should be Aware Of...

From: Imbue Botanicals Jan-30-2022 07:20:am

Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

We were sent this recent study by one of our wholesale partners and advisors, Dr. John Kim. The findings of this study are hugely important. Not only does it show that Cannabidiol (CBD) inhibits covid replication, but a real-life comparison of people who were exposed to CBD use had a significantly lower rate of positivity.

To be clear... this is not a claim for any particular product nor any medical claim in general, but is fascinating information our customers should be aware of. If you have questions about this study, please talk to your doctor or pharmacist. I can tell you that all of us here at Imbue are glad we are taking our daily dose of CBD.

With all our best,

Imbue

Abstract

The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but not congeneric cannabinoids, potently block SARS-CoV-2 replication in lung epithelial cells. CBD acts after cellular infection, inhibiting viral gene expression and reversing many effects of SARS-CoV-2 on host gene transcription. CBD induces interferon expression and up-regulates its antiviral signaling pathway. A cohort of human patients previously taking CBD had significantly lower SARSCoV-2 infection incidence of up to an order of magnitude relative to matched pairs or the general population. This study highlights CBD... READ MORE